International Reviews of Immunology

Papers
(The TQCC of International Reviews of Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Transforming growth factor-β in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting100
Regulatory Effects of Clock and Bmal1 on Circadian Rhythmic TLR Expression91
Combining the past and present to advance immuno-radiotherapy of cancer51
Breaking the graft-versus-host-disease barrier: Mesenchymal stromal/stem cells as precision healers48
Chemokines: A key driver for inflammation in protozoan infection35
Immunological and biological dissection of normal and tumoral salivary glands32
T cell receptor revision and immune repertoire changes in autoimmune diseases32
The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies28
Exploring the role of neutrophils in infectious and noninfectious pulmonary disorders27
Epigenetic regulation of T cell development21
CAR-T cells for cancer immunotherapy—the barriers ahead and the paths through19
Sentinels of innate immunity in disease pathogenesis and development of therapeutics18
An insight into COVID-19 host immunity at single-cell resolution17
Th17 cells: A new target in kidney disease research17
Molecular mechanisms of ferroptosis and their role in inflammation16
The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases15
Role of thymus in health and disease14
Immunological processes of enhancers and suppressors of long non-coding RNAs associated with brain tumors and inflammation13
Research progress on the role and mechanism of action of exosomes in autoimmune thyroid disease12
MDSCs interactions with other immune cells and their role in maternal-fetal tolerance12
Retraction12
Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy11
B7-H3-targeted CAR-T cell therapy for solid tumors9
Next generation strategies to recover immunological tolerance in celiac disease9
Dimensions of inflammation in host defense and diseases9
Gut microbiome as a treatment in colorectal cancer9
STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases9
0.058624982833862